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 Abstract 
 Background: Cardiorenal syndrome type 5 (CRS-5) includes a group of conditions character-
ized by a simultaneous involvement of the heart and kidney in the course of a systemic dis-
ease. Systemic sclerosis (SSc) is frequently involved in the etiology of acute and chronic CRS-
5 among connective tissue diseases. In SSc patients, left ventricular mass (LVM) can be used 
as a marker of nutritional status and fibrosis, while altered intrarenal hemodynamic parame-
ters are suggestive of early kidney involvement.  Methods: Forty-two consecutive patients 
with a diagnosis of SSc without cardiac and/or renal impairment were enrolled to assess 
whether cardiac muscle mass can be related to arterial stiffness. Thirty subjects matched for 
age and sex were also enrolled as healthy controls (HC). All patients performed echocardiog-
raphy and renal ultrasound.  Results: Doppler indices of intrarenal stiffness and echocardio-
graphic indices of LVM were significantly increased in SSc patients compared to HC. A positive 
correlation exists between LVM/body surface area and pulsatile index (p < 0.05, r = 0.36), re-
sistive index (p < 0.05, r = 0.33) and systolic/diastolic ratio (p < 0.05, r = 0.38). Doppler indices 
of intrarenal stiffness and LVM indices were significantly higher in SSc patients with digital 
ulcers than in SSc patients without a digital ulcer history.  Conclusions: SSc is characterized by 
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the presence of microvascular and multiorgan injury. An early cardiac and renal impairment 
is very common. LVM and intrarenal arterial stiffness can be considered as early markers of 
CRS onset. The clinical use of these markers permits a prompt identification of organ damage. 
An early diagnosis allows the appropriate setting of pharmacological management, by slow-
ing disease progression.  © 2016 S. Karger AG, Basel 
 Introduction 
 Systemic sclerosis (SSc) is a chronic connective tissue disease characterized by endo-
thelial dysfunction and fibrosis of both skin and internal organs. The hallmark of the disease 
is a vascular dysfunction involving both the macro- and microvasculature. SSc is a systemic 
disease most frequently affecting the lungs  [1] , heart  [2] , autonomic nervous system  [3] and 
kidneys  [4] . The ‘heart scleroderma’ pattern is peculiar, since, while left ventricular systolic 
dysfunction is present only in a small percentage of patients, a diastolic dysfunction is fairly 
frequent  [5] . Kidney involvement in SSc includes scleroderma renal crisis, normotensive renal 
crisis, reduced renal functional reserves and isolated reduction in glomerular filtration rate 
 [4] . However, since the heart and the kidney are connected one to another, having a very 
intense interaction, a dysfunction in one of the two organs can lead to a dysfunction of the 
other. Cardiorenal syndromes (CRS) are a group of disorders of the heart and the kidney 
whereby acute or chronic dysfunction in one organ may induce acute or chronic dysfunction 
in the other. Five types of CRS have been defined by Ronco et al.  [6] ( table 1 ). The fifth type, 
also known as ‘secondary CRS’, encompasses a group of systemic conditions that cause simul-
taneous cardiac and renal dysfunction. Recently, SSc has been included among the possible 
etiologies of CRS type 5 (CRS-5)  [7] . Our group already demonstrated that left ventricular mass 
(LVM), measured by echocardiography and normalized by body surface area (BSA), can be 
used as a marker of nutritional status and fibrosis in SSc patients  [8] . Moreover, increased 
renal arterial stiffness is known to be associated with sclerodermic kidney dysfunction  [4] , and 
we also demonstrated that Doppler indices of intrarenal stiffness are reliable predictors of 
new digital ulcer occurrence  [9] . Considering the strong relationship between the kidney and 
heart, and the frequency of simultaneous involvement of these two organs in the course of SSc, 
it would be clinically relevant to assess whether LVM can be related to intrarenal arterial 
stiffness, thus predicting a cardiorenal dysfunction before it becomes clinically evident. 
Therefore, the aim of our study is to define early diagnostic markers in CRS-5 due to SSc.
 Materials and Methods 
 Participants 
 We enrolled 42 patients with SSc (31 women and 11 men, with a mean age of 50 ± 13 years). All patients 
met the preliminary American College of Rheumatology/European League against Rheumatism criteria for 
the classification of SSc  [10] . The mean durations of Raynaud’s phenomenon (RP) and disease were 10.2 ± 
6.5 and 8.8 ± 5.3 years, respectively. Overall, 19 patients had limited cutaneous SSc (lcSSc), and 23 had diffuse 
cutaneous SSc (dcSSc), as defined by LeRoy et al.  [11] .  Table 2 shows the epidemiologic and clinical features 
of SSc patients and healthy controls (HC). 
 All SSc patients were under treatment with calcium channel blockers (nifedipine 30 mg/day). None of 
them were treated with immunosuppressive agents.
 Patients with elevated serum creatinine (sCr), elevated blood urea, urinary tract infections, abnormal 
urinary sediment, glomerulonephritis, kidney stones, anti-phospholipid-associated nephropathy, diabetes, 
cardiovascular diseases such as hypertension, myocardial infarction, arrhythmias, heart failure, pulmonary 
arterial hypertension, left ventricular dysfunction, pulmonary fibrosis, interstitial lung disease, pulmonary 
D
ow
nl
oa
de
d 
by
: 
Sa
pi
en
za
 U
ni
ve
rs
ita
 d
i R
om
a 
   
   
   
   
   
   
   
   
   
15
1.
10
0.
94
.2
00
 - 
11
/1
4/
20
16
 3
:5
0:
52
 P
M
137Cardiorenal Med 2016;6:135–142
 DOI: 10.1159/000442996 
 Gigante et al.: Left Ventricular Mass and Intrarenal Arterial Stiffness as Early Diagnostic 
Markers in Cardiorenal Syndrome Type 5 due to Systemic Sclerosis 
www.karger.com/crm
© 2016 S. Karger AG, Basel
venous occlusive disease, chronic obstructive pulmonary diseases, hyperlipidemia, coagulopathy, sclero-
derma renal crisis or smokers were excluded. None of them were under treatment with angiotensin-
converting enzyme inhibitors and/or angiotensin II receptor blockers. Thirty HC (22 females and 8 males, 
mean age 46 ± 15 years) were also recruited. The subjects’ written consent was obtained according to the 
Declaration of Helsinki. The study has been approved by the Ethics Committee of Sapienza University.
 Renal Function 
 Renal function was evaluated by the estimated glomerular filtration rate (eGFR) using the Chronic 
Kidney Disease Epidemiology Collaboration equation (CKD-EPI)  [12] .
 Echocardiography 
 LVM (g/m 2 ) was assessed by bidimensional M-mode echocardiography, using the Devereux regression 
formula  [13, 14] : LVM = 0.8 × (1.04 [(LVIDd + PWTd + SWTd) 3 – (LVIDd) 3 ]) + 0.6 g. According to the most 
recent literature, normal LVM values are  ≤ 115 g/m 2 in men and  ≤ 95 g/m 2 in women  [15] . Patients’ anthro-
pometry (weight, height, body mass index) and biochemistry were collected from charts and recorded.
 Doppler Ultrasound 
 Renal Doppler ultrasound was performed using a Toshiba Aplio Ultrasound System SSA-790 equipped 
with a convex 3.5-MHz probe. Renal Doppler flow was measured in 3 different interlobar arteries for each 
kidney guided by color-flow mapping. The following parameters were measured: peak systolic velocity, 
resistive index (RI), pulsatile index (PI) and systolic/diastolic ratio (S/D). RI was calculated as (peak systolic 
frequency shift – minimum diastolic frequency shift)/peak systolic frequency shift, and PI was calculated as 
 Table 1.  Definition of the five subtypes of CRS
CRS-1 Acute worsening of heart function leading to AKI
 CRS-2 Chronic abnormalities in heart function leading to progressive CKD
CRS-3 Acute worsening of kidney function leading to acute heart dysfunction
CRS-4 CKD leading to chronic heart disease
CRS-5 Cardiac and renal dysfunction due to acute or chronic systemic disorders
 AKI = Acute kidney injury; CKD = chronic kidney disease.
SSc HC
Females/males 31/11 22/8
Age, years 50 ± 13 46 ± 15
Body mass index 22 ± 3 22 ± 3,8
CKD-EPI, ml/min 98 ± 21 99 ± 18
Systolic blood pressure, mm Hg 115 ± 7 110 ± 10
Diastolic blood pressure, mm Hg 70 ± 15 73 ± 12
mRSS 12 ± 6.4 NA
Disease activity index 3.1 ± 2.3 NA
DSS 5.7 ± 3.6 NA
dcSSc/lcSSc 23/19 NA
SSc-specific autoantibodies
Anti-topoisomerase I 24 (57.1) NA
Anticentromere 13 (31)
None 5 (11.9)
Patients with a digital ulcer history 23 (54.8) NA
Data are given as the mean ± SD or n (%). NA = Not assessed.
 Table 2. Epidemiological and 
clinical features of HC and SSc 
patients 
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(peak systolic frequency shift/minimum diastolic frequency shift)/mean frequency shift. Then, a mean value 
of 3 measurements obtained from interlobar arteries of different parts of both kidneys was calculated.
 Weighted κ was used to evaluate the interrater reliability by the same observer. κ values for RI and S/D 
were 0.971 and 0.975, respectively. The intrapatient coefficient of variation for RI and S/D measurements 
was 1.3 and 1.4%, respectively. Calcium channel blocker therapy was discontinued 72 h before Doppler ultra-
sound examination. The mean reference value for normal RI in adults was determined to be 0.60 ± 0.10, with 
0.70 as the upper limit of normal  [16] . Patients receiving iloprost therapy underwent Doppler examination 
the day before the next infusion.
 Clinical Assessment 
 Skin thickening was assessed by the modified Rodnan total skin score (mRSS)  [17] . Disease activity was 
measured using Valentini’s Scleroderma Disease Activity Score (SDAS)  [18] , and disease severity was 
measured with the modified Medsger Scleroderma Disease Severity Scale (DSS)  [19] .
 Statistical Analysis 
 All results are expressed as mean and standard deviation (SD). Commercial software (SPSS version 
20.0) was used for statistical analysis. The coefficient of skewness and the coefficient of kurtosis were used 
to evaluate the normal distribution of data. Multiple regression analysis was made to estimate the rela-
tionship between eGFR and clinical features (e.g. age or duration of disease). To determine the independent 
association between LVM, intrarenal stiffness and digital ulcer history, we performed a multivariate analysis, 
while the Bonferroni test was used in the post hoc analysis. Group comparisons were made by Student’s 
unpaired 2-tailed t test. Pearson’s product-moment correlation coefficient (r) was used to test for an asso-
ciation between numerical variables. The χ 2 test or Fisher’s exact test, as appropriate, were used to compare 
categorical variables. The Mann-Whitney U test or Kruskal-Wallis test were used to test the differences 
between two individual study groups, and data were expressed as median and range when they were not 
normally distributed, due to the small sample. p values <0.05 were considered significant.
 Results 
 In SSc patients, eGFR using the CKD-EPI equation was 98 ± 21 ml/min. The urinalysis 
showed normal urinary sediment in all SSc patients. In HC, the eGFR value was 99 ± 18 ml/
min. The mean values of Doppler indices of intrarenal stiffness in SSc patients were: PI 1.23 
± 0.32, RI 0.61 ± 0.09 and S/D ratio 2.84 ± 0.74. In HC, the mean values were: PI 1.03 ± 0.17, 
RI 0.50 ± 0.05 and S/D ratio 2.07 ± 0.20. Therefore, Doppler indices of intrarenal stiffness 
were significantly higher in SSc patients than in HC ( table 3 ).
 In SSc patients, the mean value of LVM was 143.7 ± 40.4 g, while the LVM/BSA mean value 
was 85.6 ± 19.4 g/m 2 ; in HC, the LVM mean value was 91.6 ± 24.6 g, while the LVM/BSA mean 
value was 72.8 ± 14.1 g/m 2 . Hence, the mean values of LVM and LVM/BSA were significantly 
higher in SSc patients than in HC ( table 3 ). Moreover, a statistically significant difference was 
SSc patients HC p
Body mass index 22 ± 3.1 22 ± 3.8 n.s.
CKD-EPI, ml/min 98 ± 21 99 ± 18 n.s.
PI 1.23 ± 0.31 1.03 ± 0.17 <0.01
RI 0.62 ± 0.09 0.50 ± 0.05 0.0001
S/D ratio 2.83 ± 0.74 2.07 ± 0.20 0.0001
LVM, g 143 ± 40 91.6 ± 24.6 0.001
LVM/BSA, g/m2 85.6 ± 19.4 72.8 ± 14.1 0.001
n.s. = Not significant.
 Table 3. Body mass index, eGFR, 
Doppler indices of intrarenal 
stiffness and LVM in SSc patients 
and HC
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observed between males and females in both SSc patients and HC groups. In SSc patients, the 
mean value of LVM was significantly (p < 0.01) higher in males (170.4 ± 39.3 g) than in females 
(134.3 ± 36.9 g); similarly, LVM/BSA was significantly (p < 0.05) higher in males (92.1 ± 21.1 
g/m 2 ) than in females (80.1 ± 18.5 g/m 2 ). In the same way, in HC, the mean value of LVM was 
significantly (p < 0.001) higher in males (127.7 ± 16.8 g) than in females (78.4 ± 7.7 g), and 
LVM/BSA was significantly increased (p < 0,001) in males (92.1 ± 13.3 g/m 2 ) compared to 
females (65.8 ± 4.6 g/m 2 ).
 Furthermore, a positive correlation between age and LVM was observed in both SSc 
patients (r = 0.38, p < 0.05) and HC (r = 0.41 p < 0.05); we had a similar result for LVM/BSA 
in both SSc patients (r = 0.46, p < 0.01) and HC (r = 0.49, p < 0.01).
 Moreover, in SSc patients, we found a positive correlation between LVM/BSA and PI (p < 
0.05, r = 0.36), RI (p < 0.05, r = 0.33) and S/D ratio (p < 0.05, r = 0.38;  fig. 1 ). Furthermore, a 
significant correlation was observed between echocardiographic LVM indices (LVM and 
LVM/BSA) or Doppler indices of intrarenal stiffness and different clinical variables of the 
disease (disease duration, mRSS, Disease Activity Index and DSS). The LVM was significantly 
higher (p < 0.0001) in SSc patients with a digital ulcer history (158.8 g, range 101. 4–170) 
than in patients with no ulcer history (123.3 g, range 82–158). Similarly, the LVM/BSA was 
significantly higher (p < 0.0001) in SSc patients with a digital ulcer history (93.8 g/m 2 , range 
65–137) than in patients with no ulcer history (72.4 g, range 56.6–89.6). In the same way, 
Doppler indices of intrarenal stiffness were significantly (p < 0.0001) increased in SSc patients 
with a digital ulcer history compared to SSc patients with no history of ulcers ( table 4 ).
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p
LVM, g 158.8 (101.4 – 170) 123.3 (82 – 158) <0.0001
LVM/BSA, g/m2 93.8 (65 – 137) 72.4 (56.6 – 89.6) <0.0001
PI 1.39 (1 – 1.94) 1.03 (0.69 – 1.59) <0.0001
RI 0.69 (0.53 – 0.78) 0.56 (0.44 – 0.71) <0.0001
S/D ratio 3.30 (2.16 – 4.55) 2.30 (1.79 – 3.43) <0.0001
Figures in parentheses are ranges.
 Fig. 1. Correlation between LVM/BSA and RI ( a ) or S/D ratio ( b ) in SSc patients. 
 Table 4. Doppler indices of 
intrarenal stiffness and LVM in 
SSc patients with and those 
without a digital ulcer history
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 Doppler indices of intrarenal stiffness do not show any correlation with mRSS, disease 
duration, SDAS or DSS. Also, echocardiographic indices of LVM do not show any correlation 
with mRSS, disease duration, SDAS or DSS. In two subsets of the disease (dcSSc and lcSSc), we 
did not find significant differences in Doppler indices of intrarenal stiffness and echocardio-
graphic indices of LVM.
 Discussion 
 CRS is a condition more and more frequently observed in clinical practice  [20] . Systemic 
diseases, such as SSc, may cause acute or chronic CRS-5. In the chronic onset, it is difficult to 
establish which one, either the heart or kidney, has been involved first  [7] .
 CRS and other systemic conditions such as SSc have common pathways that lead to organ 
impairment. For this reason, identifying this syndrome can help in establishing the diagnostic 
and interventional strategies that can detect the common pathways to organ impairment in 
patients with predisposing factors for the onset of CRS at an early stage. Cardiac and renal 
involvements are common features in SSc, and an injury can develop slowly in the course of 
the disease. Since it is well known that protein-energy malnutrition may influence LVM, in a 
previous study, we have demonstrated that LVM correlates with patients’ body mass index, 
skin thickening and the vascular domain of DSS. Furthermore, we found that patients with 
ulcers had a significantly greater LVM compared to patients without skin lesions. Moreover, 
it is well known that a clinically silent kidney injury in the course of SSc can be detected by 
Doppler renal ultrasound  [21] and that RI correlates with systemic autonomic dysfunction 
 [3] , digital ulcers  [9] and erectile dysfunction  [22] . After analyzing our results, we can 
postulate that LVM/BSA correlates with intrarenal arterial stiffness as demonstrated by 
elevated RI, PI and S/D. In particular, we demonstrated that Doppler indices of intrarenal 
stiffness and LVM/BSA are increased in SSc patients compared to HC. In addition, Doppler 
indices of intrarenal stiffness are increased in SSc patients with a digital ulcer history 
compared to patients with no history of ulcers. Increased intrarenal arterial stiffness can be 
considered the first manifestation of vascular renal scleroderma impairment, and it corre-
lates with the eGFR trend  [21] . Following the relationship between intrarenal arterial stiffness 
and capillaroscopic damage, Rosato et al.  [9] demonstrated that scleroderma renal damage 
starts with an injury of the microvascular vessels. In addition, it has been demonstrated that 
response to vasodilator drugs correlates with intrarenal arterial Doppler indices  [23] . In an 
autoptic study, Follansbee et al.  [24] demonstrated that SSc patients had a greater prevalence 
of both advanced myocardial fibrosis (60%) and contraction band necrosis (40%) than HC. 
The authors concluded that in SSc patients, myocardial fibrosis is consistent with the presence 
of microvascular coronary vasospasm, a cardiac RP. Hence, these results suggest that a struc-
tural damage of vasculature occurs in many vascular districts and contributes to cardiac and 
renal dysfunction. RP is the hallmark of SSc and represents the clinical expression of a blood 
vessel spasm in the fingers, heart, kidney and other internal organs  [25, 26, 9] . Therefore, a 
diffuse RP could be considered as the trigger for chronic CRS-5. We examined both patients 
with early and late stages of disease. The vascular complication of disease (digital ulcer 
history) demonstrated an association with Doppler indices of intrarenal stiffness and echo-
cardiographic indices of LVM. In agreement with literature data, the vascular hypothesis 
plays a key role in the pathogenesis of renal and cardiac damage in asymptomatic SSc patients.
 Furthermore, apart from RP, cardiorenal involvement is supported by an increase in 
proinflammatory cytokines and increased levels of angiotensin II that result in a profibrotic, 
procoagulatory, atherogenic and arrhythmogenic state and raise oxidative stress leading to 
further cardiac and renal damage  [27] .
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 Echocardiography and Doppler renal ultrasound can provide useful information for an 
early diagnosis and management of CRS in the course of SSc. The limitation of traditional 
markers such as sCr has to be taken into account in the setting of CRS. In particular, an under-
estimated GFR reduction can be present in SSc patients despite a normal or even low sCr due 
to muscle mass wasting  [8] . The strength of our study is increased by the exclusion of patients 
with chronic kidney disease and cardiovascular abnormalities, so our results were not influ-
enced by other conditions other than SSc. However, our limitation is the small sample size 
that can weaken the power of our study, even though our results are statistically significant. 
Therefore, we can conclude that LVM and intrarenal arterial stiffness can be used as early 
markers of CRS in the course of SSc.
 Until today, there are no tests that evaluate kidney damage in SSc patients with normal 
renal function (sCr and urinary sediment) or cardiac dysfunction in SSc patients without 
pulmonary hypertension or diastolic dysfunction. Since the vascular hypothesis could play a 
key role in the pathogenesis of CRS-5, the therapy with vasoactive drugs (e.g. prostanoids) 
can be early started in SSc patients with increased Doppler indices of intrarenal stiffness or 
echocardiographic indices of LVM. Further studies with a bigger population are warranted, 
since an early diagnosis allows a prompt setting of pharmacological management to slow the 
progression of the damage.
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